Researchers believe pathway is a potential therapeutic target for gastroesophageal cancers. A team of researchers believe they have identified a cell signaling pathway responsible for the development of esophageal adenocarcinomas, an aggressive form of esophageal cancer that has gradually become more common, even in younger people.
Of the roughly 20,000 people in the U.S. diagnosed with esophageal cancer this year, just 4,000 are likely to still be alive in 2027. Such dire data has long driven researchers to try to understand the roots of the disease, but they have discovered little — until now.
“The incidence of esophageal cancers has increased several fold over the last few decades, making it the most common esophageal malignancy in the U.S...
Read More
Recent Comments